Amyloidosis: open trials in New Zealand

• NCT06128629

  MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

  Trial Treatment · Phase 3 · Intellia Therapeutics

  New Zealand Clinical Research, Auckland · New Zealand Clinical Research, Christchurch

  Registry updated 2026-11-04

• NCT07052903

  TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  Trial Treatment · Phase 3 · Alnylam Pharmaceuticals

  Auckland · Christchurch · Hamilton

  Registry updated 2026-10-20

• NCT05697861

  Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001

  Research · Phase 2/3 · Intellia Therapeutics

  Auckland

  Registry updated 2026-08-03

All Amyloidosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error